Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
10.37
-0.13 (-1.24%)
At close: Jul 15, 2026, 4:00 PM EDT
10.48
+0.11 (1.04%)
After-hours: Jul 15, 2026, 5:36 PM EDT
Omeros Employees
Omeros had 175 employees as of December 31, 2025. The number of employees decreased by 27 or -13.37% compared to the previous year.
Employees
175
Change (1Y)
-27
Growth (1Y)
-13.37%
Revenue / Employee
$56,531
Profits / Employee
$492,400
Market Cap
750.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 175 | -27 | -13.37% |
| Dec 31, 2024 | 202 | 4 | 2.02% |
| Dec 31, 2023 | 198 | 2 | 1.02% |
| Dec 31, 2022 | 196 | -17 | -7.98% |
| Dec 31, 2021 | 213 | -64 | -23.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Rigel Pharmaceuticals | 174 |
| ARS Pharmaceuticals | 159 |
| Neurogene | 131 |
| Aura Biosciences | 113 |
| Aclaris Therapeutics | 73 |
| Zevra Therapeutics | 61 |
| Oculis Holding AG | 60 |
| Climb Bio | 29 |
OMER News
- 2 days ago - Omeros Corporation Investigated by the Portnoy Law Firm - GlobeNewsWire
- 19 days ago - Omeros stock crashes on regulatory setback: buy the dip? - Invezz
- 19 days ago - Omeros price target lowered to $33 from $40 at H.C. Wainwright - TheFly
- 19 days ago - Omeros announces CHMP adopts negative opinion on MAA for narsoplimab - TheFly
- 19 days ago - Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA - Business Wire
- 27 days ago - Omeros Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Omeros Announces Webcast Details for Annual Meeting of Shareholders - Business Wire
- 4 weeks ago - Omeros trading resumes - TheFly